Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection.

× No keyword cloud information.

11 in total

Review 1. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies.

Authors: L H Calabrese; N N Zein; D Vassilopoulos
Journal: Ann Rheum Dis Date: 2006-04-20 Impact factor: 19.103

2. Subfulminant hepatitis B after infliximab in Crohn's disease: need for HBV-screening?

Authors: Gunda Millonig; Michaela Kern; Othmar Ludwiczek; Karin Nachbaur; Wolfgang Vogel
Journal: World J Gastroenterol Date: 2006-02-14 Impact factor: 5.742

Review 3. Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.

Authors: Pilar López-Serrano; Elsa de la Fuente Briongos; Elisa Carrera Alonso; Jose Lázaro Pérez-Calle; Conrado Fernández Rodríguez
Journal: World J Hepatol Date: 2015-03-27

Review 4. Interventions and targets aimed at improving quality in inflammatory bowel disease ambulatory care.

Authors: Adam V Weizman; Geoffrey C Nguyen
Journal: World J Gastroenterol Date: 2013-10-14 Impact factor: 5.742

Review 5. Use of tumor necrosis factor alpha inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action.

Authors: Matthew B Carroll; Michael A Forgione
Journal: Clin Rheumatol Date: 2010-06-16 Impact factor: 2.980

Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection.

Review 1. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies.

2. Subfulminant hepatitis B after infliximab in Crohn's disease: need for HBV-screening?

Review 3. Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.

Review 4. Interventions and targets aimed at improving quality in inflammatory bowel disease ambulatory care.

Review 5. Use of tumor necrosis factor alpha inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action.

Review 6. Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxis.

7. Reactivation of hepatitis B in a patient with Crohn's disease treated using infliximab.

Review 8. Hepatitis C virus and inflammatory bowel disease.

Review 9. Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease.

10. Long-term anti-TNFalpha therapy for ankylosing spondylitis in two patients with chronic HBV infection.